The class of SNM1A Inhibitors represents a collection of chemical entities that can influence the function of the SNM1A protein. SNM1A is involved in DNA repair processes, and these chemicals can affect its action in that context. The understanding of how these chemicals exactly inhibit SNM1A is still evolving. However, one notable theme among them is their ability to induce DNA damage or disrupt DNA repair mechanisms, in which SNM1A is a critical participant.
Some of these chemicals act by inhibiting enzymes involved in DNA repair, such as the Poly ADP ribose polymerase (PARP) enzyme. PARP plays a crucial role in the repair of single-strand DNA breaks. When inhibited, these single-strand breaks can become more severe double-strand breaks during replication. SNM1A is tasked with repairing such double-strand breaks, and inhibiting PARP can strain SNM1A's function in this regard. Other chemicals cause DNA damage directly. These include nucleoside analogues and DNA crosslinking agents. Nucleoside analogues incorporate into DNA during replication, causing DNA damage. DNA crosslinking agents form covalent bonds between different parts of the DNA molecule, leading to DNA damage. Both these types of damage can impact the function of SNM1A, as it plays a role in repairing such damage. In summary, SNM1A Inhibitors can affect SNM1A's function through their impact on DNA damage and repair mechanisms. As our understanding of these interactions continues to evolve, we anticipate a more comprehensive classification of these chemicals.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Could potentially inhibit SNM1A by introducing more DNA cross-links, thereby overwhelming its repair capacity. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Might inhibit SNM1A indirectly by increasing DNA cross-links and hindering the repair process. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $182.00 $275.00 $726.00 | 3 | |
Veliparib disrupts DNA repair, which could possibly inhibit SNM1A. | ||||||
Trifluorothymidine | 70-00-8 | sc-222370 sc-222370A | 100 mg 1 g | $179.00 $500.00 | 1 | |
Trifluridine incorporates into DNA, causing DNA damage, which could possibly inhibit SNM1A. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine causes DNA damage, which could possibly inhibit SNM1A. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Could potentially inhibit SNM1A by inducing DNA damage that SNM1A is unable to repair efficiently. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
Fludarabine causes DNA damage, which could possibly inhibit SNM1A. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Might indirectly inhibit SNM1A by causing DNA damage that overwhelms its repair mechanisms. | ||||||
Chlorambucil | 305-03-3 | sc-204682 sc-204682A | 250 mg 1 g | $52.00 $122.00 | 3 | |
Might inhibit SNM1A indirectly through its alkylating action, leading to DNA damage. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Oxaliplatin forms DNA adducts that lead to DNA damage, which could possibly inhibit SNM1A. | ||||||